COHR · Large Cap · NYSE · Technology · Scientific & Technical Instruments
Free research brief
Free to track. No card required.
Price, momentum, and the numbers behind the story.
Overall score
67/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Lowest
$280
Current price
$281.92
Median target
$420
Highest
$500
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Debt / equity
Favorable · 0.32 - strong leverage
0.32x
Current ratio
Strong · Good liquidity position
2.43x
Forward P/E
Needs attention · 112% above avg
29.93x
EV / EBITDA
Rich · Earnings can't support price
39.88x
ROIC
Weak · Weak capital efficiency
6.7%
ROE
Needs attention · Unfavorable
8.0%
COHR against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $55.20B | 68.5 | +22.5% | 67 | |
| $1.15T | 23.0 | +167.0% | 92 | |
| $5.55T | 29.1 | +83.4% | 86 | |
| $32.06B | 60.9 | +165.1% | 82 | |
| $4.38B | 22.7 | +57.0% | 82 |